Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

Shares of Boston Scientific Corp. BSX rose 1.72% to $104.12 Tuesday, on what proved to be an all-around favorable trading ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004.

Shares of Boston Scientific Corp. BSX rallied 1.05% to $102.36 Monday, on what proved to be an all-around great trading ...

Boston Scientific has put its 24-acre Minnetonka, Minnesota, campus up for sale as it continues to expand in nearby Maple Grove.

Get the latest Boston Scientific Corporation (BSX) stock news and headlines to help you in your trading and investing decisions.

Boston Scientific has become a big deal-maker under chief executive Mike Mahoney. – Topher Cox. For over a decade before the Guidant bidding war, Boston Scientific had been an aggressive deal-maker.

Boston Scientific’s Relievant Medsystems used at least 80 unclaimed bodies for training, including that of a murdered 21-year-old woman whose family was fighting to bring her home.

Learn about the executive team and board of directors at Boston Scientific Corp (BSX:XNYS) and review their bios and compensation over the latest fiscal years.

Boston Scientific endured another ordeal for much of the 2000s, over surgical mesh products used for pelvic repair in women. The company, along with several others, ...

Review quarterly and annual revenue, net income, and cash flow for Boston Scientific Corp (BSX:XNYS) stock through the last fiscal year.